Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 19, 2019
Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models
Jordi Creus-Muncunill, Michelle E Ehrlich
Neuromolecular Medicine
|
July 31, 2013
Early down-regulation of PKCδ as a pro-survival mechanism in Huntington's disease
Laura Rué, Rafael Alcalá-Vida, Graciela López-Soop, et al.
Brain Communications
|
July 7, 2025
Increased translation in adult mouse striatum is sufficient to induce motor dysfunction
Carla Castany-Pladevall, Jordi Creus-Muncunill, Maria Bergé-Gardeñes, et al.
Cell Death & Disease
|
August 1, 2020
Synaptic RTP801 contributes to motor-learning dysfunction in Huntington's disease
Núria Martín-Flores, Leticia Pérez-Sisqués, Jordi Creus-Muncunill, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 17, 2021
Striatal Cholinergic Dysregulation after Neonatal Decrease in X-Linked Dystonia Parkinsonism-Related TAF1 Isoforms
Maria-Daniela Cirnaru, Jordi Creus-Muncunill, Shareen Nelson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 18, 2021
Striatal Dopamine Induced ERK Phosphorylation Is Altered in Mouse Models of Monogenic Dystonia
Chiara Melis, Genevieve Beauvais, Brian S Muntean, et al.
Eneuro
|
September 14, 2021
Isoform-Specific Reduction of the Basic Helix-Loop-Helix Transcription Factor TCF4 Levels in Huntington's Disease
Kaja Nurm, Mari Sepp, Carla Castany-Pladevall, et al.
Molecular Neurobiology
|
February 21, 2018
Increased Levels of Rictor Prevent Mutant Huntingtin-Induced Neuronal Degeneration
Jordi Creus-Muncunill, Laura Rué, Rafael Alcalá-Vida, et al.
Journal of Neuroinflammation
|
March 8, 2024
TYROBP/DAP12 knockout in Huntington's disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration
Jordi Creus-Muncunill, Jean Vianney Haure-Mirande, Daniele Mattei, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
August 7, 2025
Sertraline treatment prevents motor dysfunction in a Huntington's disease mouse model and functional decline in patients
Marta Garcia-Forn, Carla Castany-Pladevall, Jordi Creus-Muncunill, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 19, 2019
Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models
Jordi Creus-Muncunill, Michelle E Ehrlich
Neuromolecular Medicine
|
July 31, 2013
Early down-regulation of PKCδ as a pro-survival mechanism in Huntington's disease
Laura Rué, Rafael Alcalá-Vida, Graciela López-Soop, et al.
Brain Communications
|
July 7, 2025
Increased translation in adult mouse striatum is sufficient to induce motor dysfunction
Carla Castany-Pladevall, Jordi Creus-Muncunill, Maria Bergé-Gardeñes, et al.
Cell Death & Disease
|
August 1, 2020
Synaptic RTP801 contributes to motor-learning dysfunction in Huntington's disease
Núria Martín-Flores, Leticia Pérez-Sisqués, Jordi Creus-Muncunill, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 17, 2021
Striatal Cholinergic Dysregulation after Neonatal Decrease in X-Linked Dystonia Parkinsonism-Related TAF1 Isoforms
Maria-Daniela Cirnaru, Jordi Creus-Muncunill, Shareen Nelson, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 18, 2021
Striatal Dopamine Induced ERK Phosphorylation Is Altered in Mouse Models of Monogenic Dystonia
Chiara Melis, Genevieve Beauvais, Brian S Muntean, et al.
Eneuro
|
September 14, 2021
Isoform-Specific Reduction of the Basic Helix-Loop-Helix Transcription Factor TCF4 Levels in Huntington's Disease
Kaja Nurm, Mari Sepp, Carla Castany-Pladevall, et al.
Molecular Neurobiology
|
February 21, 2018
Increased Levels of Rictor Prevent Mutant Huntingtin-Induced Neuronal Degeneration
Jordi Creus-Muncunill, Laura Rué, Rafael Alcalá-Vida, et al.
Journal of Neuroinflammation
|
March 8, 2024
TYROBP/DAP12 knockout in Huntington's disease Q175 mice cell-autonomously decreases microglial expression of disease-associated genes and non-cell-autonomously mitigates astrogliosis and motor deterioration
Jordi Creus-Muncunill, Jean Vianney Haure-Mirande, Daniele Mattei, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
August 7, 2025
Sertraline treatment prevents motor dysfunction in a Huntington's disease mouse model and functional decline in patients
Marta Garcia-Forn, Carla Castany-Pladevall, Jordi Creus-Muncunill, et al.
Page
of 2